Shiba Inu price down 11.5% after Shibarium bridge exploit
An attacker exploited the Shibarium bridge for $2.4 million after seizing validator control with a BONE flash loan
- Shibarium bridge suffered a $2.4 million exploit after the attacker took a flash loan
- Both the Shiba Inu and the BONE token were down following the attack
- The Shibarium team claims that the protocol was not compromised
Shiba Inu fell from its monthly highs after market conditions and a security incident changed investor sentiment. On Monday, Sept. 15, SHIB was trading at $0.0000131, down 11.5% from the monthly high of $0.00001482 reached on Friday, Sept. 13.
The drop from this level followed an attack on the Shibarium bridge, which saw the protocol lose $2.4 million. The attacker took out a flash loan to borrow 4.6 million BONE, enabling the attacker to gain control of 10 of 12 Shibarium validators. With this control, the attacker drained assets from the bridge.
The attack hurt confidence in Shiba Inu (SHIB) , as the token is central to the SHIB ecosystem. At the same time, confidence in the (BONE) token was hit even harder. The governance token of the Shibarium ecosystem has lost 43.5% since its monthly high of $0.341 and was trading at $0.1926.
Shibarium team denies the hack
According to the Shibarium team, the exploit does not technically constitute a hack. The team said the attacker did not compromise the protocol itself. Instead, the attacker used “stolen validator keys” to gain access to the funds.
The team also claims that the attacker moved “only a small amount” of Ethereum (ETH) and Shiba Inu tokens. Still, this line of defense did not inspire much confidence in the Shiba Inu community. Many community members and holders asked how such an attack was possible and called for an investigation.
Disclaimer: The content of this article solely reflects the author's opinion and does not represent the platform in any capacity. This article is not intended to serve as a reference for making investment decisions.
You may also like
Wall Street Stands Guard as Bessent Strikes Again: Aftereffects of August's "Treasury Turnaround" Persist, November Refinancing Notice Could Be the Next Flashpoint
As the US Treasury prepares to update its debt management plan in November, key clues may emerge on Friday.
"Coca-Cola belief" never goes out of style! KFC in America says goodbye to Pepsi and embraces Coca-Cola (KO.US); Buffett-style "boring investment" returns to the spotlight
KFC has chosen Coca-Cola as its soda supplier in the United States, abandoning its long-term partner Pepsi. As of the close of the U.S. stock market on Thursday, Coca-Cola's (KO.US) stock price reached a record high, defying the ongoing declines in global tech stocks, especially in the semiconductor and broad AI computing sectors.
AI financing concerns weigh heavily on chip stocks, global tech sector has lost over $1 trillion this week
Multiple pressures, including rising expectations of a Federal Reserve rate hike and increasing AI financing costs, have led to a massive sell-off in global tech stocks this week. The combined market value of the world's top 20 AI and semiconductor stocks has evaporated by more than $1 trillion, and the semiconductor ETF (SOXX) has recorded its longest losing streak in 11 years. On Thursday, SK Hynix continued to plunge by over 10% in a single day, while Nvidia, Samsung, and SoftBank were not spared.
Safe Haven Amid AI Crash! Major Pharmaceutical Stocks Approach Historic Highs
Amid concerns over AI capital expenditures, funds are seeking a "certainty premium." State Street Healthcare ETF reached a record high. Eli Lilly and AbbVie are both approaching their historical highest closing prices, while Gilead and Amgen have surged 7.7% and 7.2% respectively over the past five days. Eli Lilly continues to bet on the future through its GLP-1 dominance and 40 M&A deals totaling $20 billion. AbbVie's core drug Skyrizi has shown positive data for its new subcutaneous formulation, which is expected to extend its patent and drive additional sales.

